JP2004536109A - Ｕｅａ１ミメティック医薬製剤および医薬製剤用リガンド - Google Patents

Ｕｅａ１ミメティック医薬製剤および医薬製剤用リガンド Download PDF

Info

Publication number
JP2004536109A
JP2004536109A JP2003510071A JP2003510071A JP2004536109A JP 2004536109 A JP2004536109 A JP 2004536109A JP 2003510071 A JP2003510071 A JP 2003510071A JP 2003510071 A JP2003510071 A JP 2003510071A JP 2004536109 A JP2004536109 A JP 2004536109A
Authority
JP
Japan
Prior art keywords
moiety
uea1
pharmaceutical formulation
formulation according
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003510071A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004536109A5 (cg-RX-API-DMAC7.html
Inventor
ホーテン、リチャード
ピニラ、クレメンシア
ランブキン、イメルダ
オマホニー、ダニエル
ハマシン、クリスタ
シンク、エイミー
オストヒューズ−スピンドラー、リザ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sarlan Ltd
Original Assignee
Sarlan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sarlan Ltd filed Critical Sarlan Ltd
Publication of JP2004536109A publication Critical patent/JP2004536109A/ja
Publication of JP2004536109A5 publication Critical patent/JP2004536109A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2003510071A 2001-07-02 2002-07-02 Ｕｅａ１ミメティック医薬製剤および医薬製剤用リガンド Pending JP2004536109A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30282201P 2001-07-02 2001-07-02
US30286801P 2001-07-03 2001-07-03
PCT/US2002/020948 WO2003004062A1 (en) 2001-07-02 2002-07-02 Pharmaceutical formulations and ligands for use therein; mimetics for uea-1

Publications (2)

Publication Number Publication Date
JP2004536109A true JP2004536109A (ja) 2004-12-02
JP2004536109A5 JP2004536109A5 (cg-RX-API-DMAC7.html) 2006-01-05

Family

ID=26973111

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003510071A Pending JP2004536109A (ja) 2001-07-02 2002-07-02 Ｕｅａ１ミメティック医薬製剤および医薬製剤用リガンド

Country Status (7)

Country Link
US (2) US7166296B2 (cg-RX-API-DMAC7.html)
EP (1) EP1404372B1 (cg-RX-API-DMAC7.html)
JP (1) JP2004536109A (cg-RX-API-DMAC7.html)
AT (1) ATE459376T1 (cg-RX-API-DMAC7.html)
CA (1) CA2452257A1 (cg-RX-API-DMAC7.html)
DE (1) DE60235549D1 (cg-RX-API-DMAC7.html)
WO (1) WO2003004062A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007052641A1 (ja) * 2005-11-01 2007-05-10 Kumamoto University 腸管免疫賦活剤

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
KR101138312B1 (ko) * 2009-04-13 2012-04-27 주식회사 바이오에프디엔씨 펩타이드 유도체 및 그를 포함하는 화장료 조성물
WO2012156376A1 (en) 2011-05-13 2012-11-22 Merrion Pharmaceuticals Ireland Ltd. Use of plant lectins to target leukocytes

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007052641A1 (ja) * 2005-11-01 2007-05-10 Kumamoto University 腸管免疫賦活剤

Also Published As

Publication number Publication date
US7166296B2 (en) 2007-01-23
EP1404372A1 (en) 2004-04-07
DE60235549D1 (de) 2010-04-15
US20040062796A1 (en) 2004-04-01
US20060276628A1 (en) 2006-12-07
WO2003004062A1 (en) 2003-01-16
ATE459376T1 (de) 2010-03-15
CA2452257A1 (en) 2003-01-16
WO2003004062A9 (en) 2003-04-10
EP1404372B1 (en) 2010-03-03

Similar Documents

Publication Publication Date Title
JP4129298B2 (ja) 胃腸管（ｇｉｔ）輸送受容体に結合するランダムペプチド、及び関連した方法
JP5211109B2 (ja) 膜転位剤および製薬学的有効成分の複合物
US9107959B2 (en) Method for site-specific polyvalent display on polymers
JP2002502368A (ja) 組織を越える活性物質の輸送を増強するペプチドとその組成物及びその使用方法
JP2000509394A (ja) 細胞膜を横切って物質を輸送するためのポリペプチド結合体
CN104906076B (zh) 程序化多重靶向的树状大分子组装体药物递送系统及其制备方法和应用
CN110114367B (zh) Vap多肽及其在制备靶向诊疗肿瘤药物中的应用
CN106421806A (zh) 一种逐级响应纳米自组装树枝状前药及制备方法和应用
CN113292635B (zh) 靶向cd47的多肽及其应用
JP2014524477A (ja) ペプチドナノ粒子およびその使用
EP3405429B1 (en) Formation of functionalized nanoparticles by supramolecular co-assembly
US20090238886A1 (en) Retro-Inversion Peptides That Target GIT Transport Receptors and Related Methods
KR20170075367A (ko) 표면전하 전환형 약물전달용 나노입자 및 이의 제조방법
JP2004536109A (ja) Ｕｅａ１ミメティック医薬製剤および医薬製剤用リガンド
WO2006061101A2 (en) Drug delivery peptides for crossing blood-brain barrier
CN101610759A (zh) 由跨膜肽组成的自组装纳米颗粒及其用于特异性肿瘤内递送抗癌药物的应用
CN109675048A (zh) 一种抗癌前药脂质体及青蒿素类脂质体纳米药物
TR201723077A2 (tr) Ultrases duyarli manyeti̇k hedefli̇ nano i̇laç taşiyici si̇stem
WO1994011015A1 (en) Lipophilic peptide-based carriers for targeted drug delivery using rational drug-binding design
EP3952912B1 (en) Cell-penetrating conjugate systems
WO2020119773A1 (zh) 两性霉素b肽衍生物
WO2026002308A1 (zh) 靶向her2的多肽偶联药物及其制备方法和应用
CN118556068A (zh) Cd44结合肽试剂和方法
CN111973555A (zh) 抗肿瘤和抗肿瘤转移的双pH敏感聚合物-药物偶联物混合胶束组合物
NZ622045B2 (en) Peptide nanoparticles and uses thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050701

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050701

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090414

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090714

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090722

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090812

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090819

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090819

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20091104